Paper #936

Títol:

R&D in the pharmaceutical industry: A world of small innovations

Autors:

Beatriz Domínguez, Juan José Ganuza i Gerard Llobet

Data:

Desembre 2005

Resum:

It is commonly argued that in recent years pharmaceutical companies have directed their R&D towards small improvements of existing compounds instead of more risky drastic innovations. In this paper we show that the proliferation of these small innovations is likely to be linked to the lack of market sensitivity of a part of the demand to changes in prices. Compared to their social contribution, small innovations are relatively more profitable than large ones because they are targeted to the smaller but more inelastic part of the demand. We also study the effect of regulatory instruments such as price ceilings, copayments and reference prices and extend the analysis to competition in research.

Paraules clau:

Health-care, pharmaceuticals, innovation

Codis JEL:

I11, I18, L51, O31

Àrea de Recerca:

Economia de l'Empresa i Organització Industrial / Microeconomia / Economia Laboral, Pública, de Desenvolupament i de la Salut

Descarregar el paper en format PDF (257 Kb)